NCT01025024

Brief Summary

A single-nucleotide polymorphism (SNP) analysis of DNA obtained from peripheral blood of the glaucoma patients and the normal control will be performed to find genetic marker for primary open angle glaucoma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,224

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2007

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2009

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2009

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 2, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 3, 2009

Completed
Last Updated

December 3, 2009

Status Verified

December 1, 2009

Enrollment Period

2.8 years

First QC Date

December 2, 2009

Last Update Submit

December 2, 2009

Conditions

Keywords

SNPsingle-nucleotide polymorphismglaucomaprimary open angle glaucoma

Outcome Measures

Primary Outcomes (1)

  • genotyping for the SNP associated with primary open angle glaucoma

    one year

Secondary Outcomes (1)

  • genotyping for rs7961953 and additional SNPs in TMTC2 from other linkage disequilibrium patterns

    one year

Study Arms (2)

POAG group

Elevated intraocular pressure normal open angle glaucomatous optic nerve head abnormality glaucomatous visual field defect

Genetic: SNP analysis of the DNA

Normal control

Normal intraocular pressure No optic disc abnormality No visual field defect No significant ocular and systemic disease

Genetic: SNP analysis of the DNA

Interventions

SNP analysis of the DNA obtained from peripheral blood sample

Normal controlPOAG group

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with open angle glaucoma who visited glaocoma clinic of departemtn of Ophtalmology, Chungnam National University Hospital, Daejeon, south Korea

You may qualify if:

  • Clinical diagnosis of primary open angle glaucoma

You may not qualify if:

  • Primary open angle glaucoma combined with congenital ocular disease
  • Primary open angel glaucoma combined with other ocular disease
  • Significant systemic disease other than systemic hypertension and diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chungnam National University Hospital

Daejeon, 301-721, South Korea

Location

Biospecimen

Retention: SAMPLES WITH DNA

Peripheral blood sample

MeSH Terms

Conditions

GlaucomaGlaucoma, Open-Angle

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Officials

  • Chang-sik Kim, professor

    Department of Ophthalmology, Chungnam National University Hospital

    PRINCIPAL INVESTIGATOR
  • Changwon Kang, professor

    Korea Advanced Institute of Science and Technology

    STUDY CHAIR
  • Kyunglan Kim

    Department of Biological Sciences, Korea Advanced Institute of Science and Technology

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 2, 2009

First Posted

December 3, 2009

Study Start

January 1, 2007

Primary Completion

October 1, 2009

Study Completion

November 1, 2009

Last Updated

December 3, 2009

Record last verified: 2009-12

Locations